Search Results
Aug 31, 2026, 07:00 ET New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Obesity-Psoriasis Connection: Prevalence, Incidence, and Comorbidity Insights from a Large US Population of 19.9 Million (2018-2024). Presented at Maui Derm, 2026.2 Estimated from a large real-world population of care-seeking adults in the US in 2024, Truveta (data on file). Comorbidities
More news about: Eli Lilly and Company
Aug 18, 2026, 22:26 ET /C O R R E C T I O N -- Obagi Medical/
and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne,
More news about: Obagi Medical
Jul 28, 2026, 08:00 ET Chronic Itch in Dogs and Cats May Look Like Normal Licking and Grooming
Hill's® Prescription Diet® Derm Complete Dry Dog Food.†† Discount automatically applies, and no code is required.A veterinary prescription is required for Cytopoint®, Apoquel® and Hill's® Prescription Diet® Derm Complete Dry Dog Food. Offers
More news about: Thrive Pet Healthcare
Jul 16, 2026, 10:09 ET SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS
came on May 7, 2026, when first quarter 2026 results revealed significant deterioration. The Company admitted that "share loss is being amplified by a derm market with declining patient volume in the clinic" and that competition had "not yet translated into overall market expansion." Analysts cut estimates
More news about: SueWallSt.com
Jul 16, 2026, 09:59 ET Curology and Walmart Join Forces to Expand Access to Prescription Acne Care Nationwide
First-of-Its-kind partnership brings relief to "Derm Deserts" by pairing innovative online care with Walmart retail presenceSAN DIEGO, July 16, 2026 /PRNewswire/ --
More news about: Curology
Jun 24, 2026, 10:09 ET Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
comparable or superior to Apoquel in head-to-head studies at a lower costBy Q1 2026, the Company admitted that "share loss is being amplified by a derm market with declining patient volume in the clinic"Pet owners demonstrated "increased price sensitivity," further compressing prescription
More news about: Levi & Korsinsky, LLP
Jun 23, 2026, 03:00 ET AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study. Acta Derm Venereol. 2022;102:adv00660. Published 2022 Feb 28. doi:10.2340/actadv.v101.981
More news about: AbbVie
Jun 23, 2026, 03:00 ET AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study. Acta Derm Venereol. 2022;102:adv00660. Published 2022 Feb 28. doi:10.2340/actadv.v101.981
More news about: AbbVie
Jun 22, 2026, 08:28 ET Sunglasses + SPF. Why Hasn't Anyone Thought of This Before?
products were tested by Sunski's community across trails, surf breaks, chairlifts, road trips, city walks, and mountain mornings.Lab-tested. Derm-tested. Adventure-tested.Since 2012, Sunski has grown from a Kickstarter campaign into a global outdoor lifestyle brand built around one simple idea:
More news about: Sunski
Jun 15, 2026, 19:01 ET The AI from Skin Analytics that caught 20,000 cancers in the UK is now certified for use on a standard smartphone
diagnosis."Skin Analytics is working with European partners to make DERM Zero available from June 2026.DERM Zero was unveiled at HLTH Europe in Amsterdam on 16th June 2026.How Derm Zero worksDerm Zero is powered by DERM, an AI system trained over more than a decade on a large dataset
More news about: Skin Analytics
Jun 15, 2026, 19:01 ET La IA que ha detectado 20.000 cánceres en Reino Unido ya está certificada para usarse en smartphone1
Unión Europea para que DERM Zero esté disponible a partir de junio de 2026.DERM Zero se presentó en HLTH Europe en Ámsterdam el 16 de junio de 2026.Cómo funciona DERM Zero:DERM Zero está impulsado por DERM, una IA entrenada durante
More news about: Skin Analytics
Jun 15, 2026, 19:01 ET L'IA qui a détecté 20 000 cas de cancer au Royaume-Uni est désormais certifiée pour une utilisation sur un smartphone
collabore avec des partenaires européens afin de rendre DERM Zero disponible à partir de juin 2026.DERM Zero a été dévoilé lors du salon HLTH Europe à Amsterdam le 16 juin 2026.Comment fonctionne Derm ZeroDerm Zero s'appuie sur DERM, un système d'intelligence artificielle entrainé
More news about: Skin Analytics
Jun 11, 2026, 09:00 ET Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
comparable or superior to Apoquel in head-to-head studies at a lower costBy Q1 2026, the Company admitted that "share loss is being amplified by a derm market with declining patient volume in the clinic"Pet owners demonstrated "increased price sensitivity," further compressing prescription
More news about: SueWallSt.com
Jun 09, 2026, 08:00 ET HILL'S PET NUTRITION LAUNCHES PREMIERE NUTRITION SUPPORTING KIDNEY FUNCTION PLUS GI AND SKIN SENSITIVITIES
Hill's Prescription Diet k/d + Derm Complete for dogs and k/d + z/d Hydrolyzed for cats are now available via veterinarian recommendationOVERLAND PARK, Kan., June 9, 2026 /PRNewswire/ --
More news about: Hill's Pet Nutrition
Jun 04, 2026, 17:33 ET ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
and that Trio had "not experienced year-over-year patient share loss"By May 2026, the Company admitted "share loss is being amplified by a derm market with declining patient volume in the clinic"The $2.5 billion dermatology TAM projection (11% CAGR) that underpinned Zoetis' premium
More news about: SueWallSt.com
Jun 03, 2026, 09:00 ET ZTS DEADLINE: Levi & Korsinsky Reminds Zoetis Inc. Investors of Upcoming Securities Class Action Deadline
2026 results exposed significant deterioration across the entire Companion Animal business. The Company admitted share loss was "being amplified by a derm market with declining patient volume in the clinic," that pet owners demonstrated "increased price sensitivity," and that new competitive entrants had
More news about: Levi & Korsinsky, LLP
May 19, 2026, 12:00 ET Hill's Pet Nutrition Announces 2026 Hill's Global Symposium - "Healthy Skin Starts From Within" - Exploring the Gut-Skin Axis
power of the microbiome and its influence on overall pet health, and are proud to equip veterinarians with the latest innovations to manage complex derm and gastrointestinal cases."More than 10 renowned veterinary experts will provide insights and practical applications to guide clinical decision-making,
More news about: Hill's Pet Nutrition
May 19, 2026, 12:00 ET Hill's Pet Nutrition Announces 2026 Hill's Global Symposium - "Healthy Skin Starts From Within" - Exploring the Gut-Skin Axis
power of the microbiome and its influence on overall pet health, and are proud to equip veterinarians with the latest innovations to manage complex derm and gastrointestinal cases."More than 10 renowned veterinary experts will provide insights and practical applications to guide clinical decision-making,
More news about: Hill's Pet Nutrition
May 19, 2026, 10:00 ET Hill's Pet Nutrition Announces 2026 Hill's Global Symposium - "Healthy Skin Starts From Within" - Exploring the Gut-Skin Axis
power of the microbiome and its influence on overall pet health, and are proud to equip veterinarians with the latest innovations to manage complex derm and gastrointestinal cases."More than 10 renowned veterinary experts will provide insights and practical applications to guide clinical decision-making,
More news about: Hill's Pet Nutrition
May 15, 2026, 16:01 ET Propedix Announces Appointment of Dr. Mercedes E. Gonzalez to its Clinical Advisory Board
Dr. Gonzalez is the founder and Medical Director of Derm360 and Medical Director of Pediatric Skin Research, LLC. She holds academic appointments as Clinical Assistant Professor of Dermatology at Florida International
More news about: Propedix Inc.
May 13, 2026, 08:00 ET CeraVe Appoints NBA Icon Carmelo Anthony as Its "Head Coach"
dome," giving a new meaning to his famous celebration signage."We've seen the cultural traction of our NBA partnership and our 'Moisturize Like a Derm' campaign with Kevin Durant, proving that by engaging authentic voices to address common skin concerns, we can drive meaningful and impactful conversations,"
More news about: CeraVe
May 12, 2026, 10:15 ET DERMA E Reintroduces Itself with a Bold New Direction and Fresh Campaign, "A Lil' Derm Goes a Long Way," Reinforcing Dermatologist-Backed Skincare and New Packaging
approach to product education, and a new campaign celebrating dermatologist-recommended skincare brought to life through the tagline, "A Lil' Derm Goes a Long Way."
More news about: DERMA E
May 07, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
May 01, 2026, 08:01 ET Misinformation puts over 16 million Americans at an increased risk for skin cancer
because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or
More news about: American Academy of Dermatology
Apr 30, 2026, 22:40 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP